小児の不眠症
Rayan Kteish1, Mathew Ednick1, Catherine Kier1
1Stony Brook Children's Hospital, Renaissance School of Medicine, Stony Brook, New York.
Abstract:
Pediatric insomnia is a common condition that can significantly impact a patient's well-being. It typically involves difficulty falling asleep, staying asleep, or both. The prevalence of insomnia is notably higher among children with autism spectrum disorder (ASD) or attention-deficit hyperactivity disorder (ADHD). Two commonly recognized subtypes of pediatric insomnia are behavioral insomnia and psychophysiological insomnia. Because clinical symptoms and physical examination findings are often subtle, pediatricians should be familiar with the diagnosis and management of insomnia. Pediatricians should also consider and rule out underlying disorders such as sleep apnea, anxiety, or other medical conditions that may contribute to or mimic insomnia. Cognitive behavioral therapy for insomnia (CBT-I) is currently regarded as the most effective treatment. While melatonin has shown benefits in children with autism or ADHD, additional research is needed to evaluate the efficacy of other pharmacologic options. Timely intervention is crucial, as pediatric insomnia can become chronic and negatively affect mental health and overall quality of life.
関連する概念動画
Pharmacokinetics in Pediatric Patients: Drug Excretion
Management of Insomnia
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Insomnia
Multiple factors contribute...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...


